Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Stable Coronary Heart Disease and Hyperlipidemia
NCT01382277Phase 4Unknown
- Sponsor
- Peking University First Hospital
- Start
- Mar 2011
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in hyperlipidemia, coronary artery disease (CAD), sponsored by Peking University First Hospital. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
hyperlipidemiacoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01382277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382277.